Post-vaccination surveillance is crucial for promptly detecting outbreaks of avian influenza and proving disease freedom, enabling the safe movement of birds.

EFSA and ANSES brought together global expertise to foster collaboration and shape the future of horizon scanning.

New report by EFSA and ECDC assesses risk factors that could determine the evolution of the AI virus and possible mitigation measures.

Levels of residues from veterinary drugs found in animals and animal-derived food remain low in the European Union.

Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to the latest EFSA and ECDC report on AMR.

Countries that have decreased their consumption of antibiotics in both animals and humans have seen a reduction in antibiotic-resistant bacteria. This is according to the fourth joint JIACRA report by...

EFSA scientists routinely evaluate the safety of novel proteins in the GMO and novel foods areas. Our evaluations include the safety of the production process used to manufacture the product under...

This is the finding of EFSA’s opinion on the public health risk linked to the presence of inorganic arsenic in food, confirming the outcome of EFSA’s previous assessment from 2009.

In recent weeks, detections of highly pathogenic avian influenza (HPAI) viruses in wild birds in Europe have risen, although the increase began later than in previous years. This is possibly due to a...

Ready-to-eat fish products, mainly smoked salmon, are the likely source of an ongoing multi-country outbreak of Listeria monocytogenes.

Campylobacteriosis and salmonellosis were the most frequently reported zoonotic diseases in humans in the EU in 2022. However, the number of cases was still lower than during the pre-pandemic years...

In October 2023, the European Commission sent two mandates to EFSA to deliver scientific opinions on the welfare of turkeys and beef cattle on farms.